Intuitive Surgical (NASDAQ:ISRG) Stock Price Expected to Rise, BTIG Research Analyst Says

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) had its target price raised by BTIG Research from $454.00 to $513.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the medical equipment provider’s stock. BTIG Research‘s target price indicates a potential upside of 25.97% from the stock’s current price.

Several other research analysts also recently weighed in on ISRG. Leerink Partners set a $503.00 target price on Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday, October 21st. Robert W. Baird lifted their price target on shares of Intuitive Surgical from $513.00 to $550.00 and gave the company an “outperform” rating in a research note on Wednesday, October 21st. TD Cowen reissued a “buy” rating and issued a $485.00 price target on shares of Intuitive Surgical in a research note on Monday, October 19th. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Wednesday, October 21st. Finally, Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, October 31st. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $495.90.

Read Our Latest Research Report on ISRG

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $407.24 on Wednesday. The firm has a 50-day simple moving average of $422.91 and a two-hundred day simple moving average of $428.31. The company has a market cap of $141.17 billion, a P/E ratio of 47.19, a price-to-earnings-growth ratio of 2.90 and a beta of 1.45. Intuitive Surgical has a fifty-two week low of $328.57 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The business had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. During the same period in the prior year, the company posted $2.40 EPS. The company’s revenue for the quarter was up 21.7% on a year-over-year basis. Equities research analysts forecast that Intuitive Surgical will post 9.37 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $458.15, for a total transaction of $183,260.00. Following the transaction, the executive vice president owned 6,236 shares of the company’s stock, valued at approximately $2,857,023.40. The trade was a 6.03% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia Wadors sold 1,078 shares of the company’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $443.80, for a total transaction of $478,416.40. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 39,317 shares of company stock worth $17,720,016. Corporate insiders own 0.60% of the company’s stock.

Institutional Trading of Intuitive Surgical

Institutional investors have recently made changes to their positions in the company. Bank of America Corp DE increased its stake in Intuitive Surgical by 3.3% during the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after acquiring an additional 116,292 shares during the last quarter. Bank of New York Mellon Corp purchased a new stake in Intuitive Surgical in the second quarter valued at $1,335,753,000. Amundi lifted its stake in shares of Intuitive Surgical by 8.6% in the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after purchasing an additional 193,096 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in shares of Intuitive Surgical by 95.3% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after purchasing an additional 1,027,475 shares during the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. lifted its stake in shares of Intuitive Surgical by 10.8% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock valued at $769,948,000 after purchasing an additional 184,044 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are a few of the latest headlines about ISRG:

  • Positive Sentiment: BTIG raised its price target to $513 from $454 and maintained a Buy rating, signaling increased analyst confidence in potential upside. BTIG analyst rating
  • Neutral Sentiment: Coverage says ISRG was down 1.7% since its earnings report about a month ago and points investors to upcoming earnings estimates for clues on a possible rebound, without providing a specific estimate change. ISRG performance since earnings
  • Negative Sentiment: A valuation analysis says the shares may be near fair value despite strong revenue growth, citing competitive pressure and new robotic platforms that could limit upside. Valuation and competition analysis

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.

Further Reading

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.